–
Artiva Biotherapeutics, Inc.
Metrics score locked — part of Premium
FY21
FY22
FY23
FY24
FY25
FY21 – FY25
(positive)
Change from FY23 to FY25
millions USD
FY21:
FY22:
–
FY23:
−47.4
FY24:
−55.0
FY25:
−76.8
Change from FY23 to FY25
millions USD
FY21:
–
FY22:
–
FY23:
−26.0
FY24:
−120
FY25:
63.4
Change from FY23 to FY25
millions USD
FY21:
–
FY22:
–
FY23:
24.4
FY24:
162
FY25:
0.01
millions USD
FY21:
–
FY22:
–
FY23:
−49.0
FY24:
−13.3
FY25:
−13.3
(positive)
Change from FY21 to FY25
millions USD
FY21:
−17.0
FY22:
−57.1
FY23:
−50.7
FY24:
−55.7
FY25:
−79.3
All amounts in millions USD FY21, FY22: figures supplemented from Twelve Data because the SEC filings do not reach back this far.